We observed that ERBB2-induced breast cancer heterogeneity was associated with different molecular subphenotypes at the level of both the tumor pathophenotypes and the prognosis clusters (Figure 7; Figure S7B in Additional file 2). The gene discussed is ERBB2; the disease is neoplasm.